Immunoaffinity resin for purification of urinary leukotriene E4

Prostaglandins and Other Lipid Mediators

Volumn 55, Issue 5-6, 1998, Pages 301-321

  Westcott, Jay Y ^a   Maxey, Kirk M ^b   MacDonald, Jim ^b   Wenzel, Sally E ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b Cayman Chemical Company   (United States)

Author keywords

Immunoaffinity resin; Leukotriene E4; Urine

Indexed keywords

LEUKOTRIENE E4; PEPTIDOLEUKOTRIENE;

ANTIBODY AFFINITY; ARTICLE; CHILD; CREATININE BLOOD LEVEL; ENZYME IMMUNOASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PROTEIN PURIFICATION; PURIFICATION; STATISTICAL ANALYSIS; URINALYSIS;

ADULT; ANTIBODIES, MONOCLONAL; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, AFFINITY; HEMOCYANIN; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOSORBENTS; LEUKOTRIENE E4; MIDDLE AGED; REPRODUCIBILITY OF RESULTS;

EID: 0032051447     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(98)00027-6     Document Type: Article

References (31)

1. Arm J.P., Lee T.H. Sulphidopeptide leukotrienes in asthma. Clin. Sci. 84:1993;501.
2. Henderson W.R. Jr. The role of leukotrienes in inflammation. Ann. Intern. Med. 121:1994;684.
3. Busse W.W. The role of leukotrienes in asthma and allergic rhinitis. Clin. Exp. Allergy. 26:1996;868.
4. 4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet. 1:1989;584.
5. 4 . Biochem. Biophys. Res. Commun. 130:1985;214.
6. Westcott J.Y., Johnston K., Batt R.A., Wenzel S.E., Voelkel N.F. Measurement of peptidoleukotrienes in biological fluids. J. Appl. Physiol. 68:1990;2640.
7. Wenzel S.E., Trudeau J.B., Kaminsky D.A., et al. Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. Am. J. Respir. Crit. Care Med. 152:1995;897.
8. Christie P.E., Tagari P., Ford-Hutchinson A.W., et al. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am. Rev. Respir. Dis. 143:1991;1025.
9. Fauler J., Thon A., Tsikas D., von der Hardt H., Frolich J.C. Enhanced synthesis of cysteinyl leukotrienes in juvenile rheumatoid arthritis. Arthritis Rheum. 37:1994;93.
10. Allen S.P., Sampson A.P., Piper P.J., et al. Enhanced excretion of urinary leukotriene E4 in coronary artery disease and after coronary artery bypass surgery. Coron. Artery Dis. 4:1993;899.
11. 4 levels are elevated in patients with active systemic lupus erythematosus. J. Rheumatol. 19:1992;252.
12. Asano K., Lilly C.M., O'Donnell W.J., et al. Diurnal variation of urinary leukotriene E4 and histamine excretion rates in normal subjects and patients with mild-to-moderate asthma. J. Allergy Clin. Immunol. 96:1995;643.
13. 4 in humans. Clin. Exp. Allergy. 25:1995;467.
14. Kumlin M. Analytical methods for the measurement of leukotrienes and other eicosanoids in biologic samples from asthmatic subjects. J. Chromatog. A. 725:1996;29.
15. Westcott J.Y., Sloan S., Wenzel S.E. Immunofiltration purification for urinary leukotriene quantitation. Anal. Biochem. 248:1997;202.
16. 4. Biochim. Biophys. Acta. 1081:1991;274.
17. Tagari P., Ethier D., Carry M., et al. Measurement of urinary leukotrienes by reversed-phase liquid chromatography and radioimmunoassay. Clin. Chem. 35:1989;388.
18. 4 in human urine from asthmatics. J. Chromatogr. 526:1990;341.
19. 4 from human urine . Prostaglandins. 43:1992;523.
20. 4 in patients with asthma. Effect of airways reactivity and sodium cromoglycate. Am. Rev. Respir. Dis. 143:1991;1322.
21. 4 elimination and metabolism in normal human subjects. J. Biol. Chem. 265:1990;21771.
22. Fauler J., Neumann C., Tsikas D., Frolich J. Enhanced synthesis of cysteinyl leukotrienes in atopic dermatitis. Br. J. Dermatol. 128:1993;627.
23. Denzlinger C., Tetzloff W., Gerhartz H.H., et al. Differential activation of the endogenous leukotriene biosynthesis by two different preparations of granulocyte-macrophage colony-stimulating factor in healthy volunteers. Blood. 81:1993;2007.
24. 4 in humans. Effect of indomethacin. Am. Rev. Respir. Dis. 141:1990;1441.
25. 4 in bronchial asthma. Eur. Respir. J. 5:1992;693.
26. 4 after exercise challenge in children with asthma. J. Allergy Clin. Immunol. 89:1992;1111.
27. 4, and histamine in asthmatics. Am. Rev. Respir. Dis. 146:1992;96.
28. 4 concentrations in aspirin-sensitive asthma. Am. J. Respir. Crit. Care Med. 151:1995;1326.
29. Israel E., Fischer A.R., Rosenberg M.A., et al. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am. Rev. Respir. Dis. 148:1993;1447.
30. 4 during aspirin-induced asthma. J. Lab. Clin. Med. 119:1992;48.
31. 4 excretion in patients with ARDS and severe burns. Prostaglandins Leukot. Essent. Fatty Acids. 43:1991;151.